Quantifying benefit–risk preferences for medical interventions: an overview of a growing empirical literature
A Brett Hauber, AO Fairchild… - Applied health economics …, 2013 - Springer
Decisions regarding the development, regulation, sale, and utilization of pharmaceutical and
medical interventions require an evaluation of the balance between benefits and risks. Such …
medical interventions require an evaluation of the balance between benefits and risks. Such …
Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data
M Bewtra, FR Johnson - The Patient-Patient-Centered Outcomes …, 2013 - Springer
Inflammatory bowel disease (IBD), consisting of both Crohn's disease (CD) and ulcerative
colitis (UC), are chronic inflammatory conditions of the intestinal tract. As there is no cure for …
colitis (UC), are chronic inflammatory conditions of the intestinal tract. As there is no cure for …
Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune‐mediated diseases
K Haynes, T Beukelman, JR Curtis… - Arthritis & …, 2013 - Wiley Online Library
Objective To compare the incidence of cancer following tumor necrosis factor α (TNFα)
inhibitor therapy to that with commonly used alternative therapies across multiple immune …
inhibitor therapy to that with commonly used alternative therapies across multiple immune …
May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel …
Background: Nurses play an important role in educating patients with inflammatory bowel
disease (IBD) about immunosuppressive or biological therapy during prescribing …
disease (IBD) about immunosuppressive or biological therapy during prescribing …
[HTML][HTML] A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis
OBJECTIVE: To assess patient preferences for treatment-related benefits and risks
associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in the …
associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in the …
Perceptions of health status in multiple sclerosis patients and their doctors
M Kremenchutzky, L Walt - Canadian journal of neurological …, 2013 - cambridge.org
Objective: To compare neurologist and patient perceptions of multiple sclerosis (MS)-related
health status. Methods: MS patients (n= 99) were recruited from six sites in Canada …
health status. Methods: MS patients (n= 99) were recruited from six sites in Canada …
[HTML][HTML] An agent-based simulation model for informed shared decision making in multiple sclerosis
M Veloso - Multiple sclerosis and related disorders, 2013 - Elsevier
Shared decision making (SDM) is concerned with patient involvement into medical
decisions and chronic conditions such as Multiple sclerosis (MS), with only partially effective …
decisions and chronic conditions such as Multiple sclerosis (MS), with only partially effective …
Turning the spotlight on experimental design in discrete choice experiments—A focus on pragmatic approaches in health
JA Whitty, TL Kauf - Value in Health, 2013 - valueinhealthjournal.com
Stated preference techniques including the discrete choice experiment (DCE) provide a
fundamental and increasingly popular method to evaluate the trade-offs people are willing to …
fundamental and increasingly popular method to evaluate the trade-offs people are willing to …
[HTML][HTML] Taking Crohn's disease personally
Y Chowers - Rambam Maimonides Medical Journal, 2013 - ncbi.nlm.nih.gov
Crohn's disease (CD) is a heterogeneous disorder that can involve any segment of the
gastrointestinal tract. The pathogenesis of CD is unknown but is thought to involve an …
gastrointestinal tract. The pathogenesis of CD is unknown but is thought to involve an …
[PDF][PDF] A. Brett Hauber, Angelyn O. Fairchild &
FR Johnson - researchgate.net
Decisions regarding the development, regulation, sale, and utilization of pharmaceutical and
medical interventions require an evaluation of the balance between benefits and risks. Such …
medical interventions require an evaluation of the balance between benefits and risks. Such …